Drug firm Indoco Remedies on Friday said it has received accreditation from the UK-MHRA (Medicines and Healthcare Products Regulatory Agency) for its Hyderabad-based clinical research organisation (CRO)- AnaCipher.

The entity has received GCP and GLP Accreditation from the UK-MHRA after a virtual inspection carried out from May 4 – May 7 and May 10 - May 11, 2021.

The inspection covered all the phases of bioequivalence studies, Indoco Remedies said in a regulatory filing.

"This is an exciting step in our journey of excellence and a validation of our adherence to delivering quality services to our customers worldwide," Indoco Remedies MD Aditi Kare Panandikar said.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)